碳离子放疗治疗两例不可手术的放疗后骨肉瘤患者的长期生存:病例报告
两例宫颈癌放疗后发生不可手术盆腔骨肉瘤的患者,分别于既往放疗后112.8和172.2个月确诊,均接受70.4 Gy(相对生物效应)分16次碳离子放疗并配合化疗,1年后均达完全缓解;其中一例在碳离子放疗开始后12.6个月出现单发肺转移并接受胸腔镜肺叶切除术,两例分别在碳离子放疗开始后63.7和89.0个月存活,无局部复发、其他远处转移或致命毒性。作者认为碳离子放疗是不可手术放疗后骨肉瘤的合适治疗选择。
要点
- 两例不可手术放疗后盆腔骨肉瘤均接受70.4 Gy(相对生物效应)分16次碳离子放疗并配合化疗。
- 碳离子放疗开始后1年两例均达完全缓解,其中一例在12.6个月出现单发肺转移并接受胸腔镜肺叶切除术。
- 碳离子放疗开始后63.7和89.0个月两例均存活,无局部复发、其他远处转移或致命毒性。
核心结论
- 作者认为碳离子放疗是不可手术放疗后骨肉瘤的合适治疗选择。
研究设计与样本
- 病例报告,报告两例宫颈癌治疗后发生不可手术放疗后盆腔骨肉瘤并接受碳离子放疗的患者。
主要发现
- 两例从既往放疗到确诊放疗后骨肉瘤的时长分别为112.8和172.2个月。
- 两例均接受70.4 Gy(相对生物效应)分16次碳离子放疗,并在碳离子放疗前后进行化疗。
- 两例在碳离子放疗开始后1年均达到完全缓解。
- 一例在碳离子放疗开始后12.6个月出现单发肺转移并接受胸腔镜肺叶切除术。
- 两例分别在碳离子放疗开始后63.7和89.0个月存活,无局部复发、其他远处转移或致命毒性。
关键数值与推荐
- 碳离子放疗剂量为70.4 Gy(相对生物效应),分16次给予。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Curative treatment of inoperable post-irradiation sarcoma is often challenging, especially using radiotherapy, wherein curative dose administration is difficult because the organs around the tumor have already been irradiated during the first cancer treatment. Carbon-ion radiotherapy (C-ion RT) might be useful in the treatment of post-irradiation sarcomas because it allows re-irradiation with high-dose localization properties and also demonstrates higher cytotoxic effects on radioresistant tumors compared with X-rays. This study presents the long-term survival of two patients with inoperable post-irradiation pelvic osteosarcoma treated with C-ion RT after uterine cervical cancer treatment. CASE PRESENTATION: The durations from prior radiotherapy to the diagnosis of post-irradiation osteosarcoma were 112.8 and 172.2 months, respectively. Both patients received 70.4 Gy (relative biological effectiveness) in 16 fractions of C-ion RT, and chemotherapy was performed before and after C-ion RT. Both patients achieved a complete response 1 year after the initiation of C-ion RT. However, one patient developed single lung metastasis 12.6 months after the initiation of C-ion RT and underwent thoracoscopic lobectomy. After 63.7 and 89.0 months from the initiation of C-ion RT, respectively, the patients were alive with no evidence of local recurrence, other distant metastasis, or fatal toxicities. CONCLUSIONS: The study findings suggest that C-ion RT is a suitable treatment option for inoperable post-irradiation osteosarcoma.
引用
- Shiba S, Okamoto M, Yanagawa T, et al. Long-term survival of two patients with inoperable post-irradiation osteosarcoma treated with carbon-ion radiotherapy: a case report. Radiat Oncol. 2022. PMID: 35379287. doi:10.1186/s13014-022-02040-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。